转化生长因子-β信号转导与肿瘤
摘要
TGFβ超家族由一大类具有相似生物学特征的细胞因子组成。其信号转导途径复杂 ,涉及多种生物分子。影响因素众多 ,且影响因素间存在交叉作用 ;信号转导成员变异如受体突变、作用底物
出处
《国外医学（临床生物化学与检验学分册）》
2003年第3期156-157,共2页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
参考文献15
-
1Kingsley DM. The TGF-beta superfamily: new members,new receptors, and new genetic tests of function in different organisms[J]. Genes Dev, 1994,8( 1 ), 133-146.
-
2de Caestecker MP,Piek E, Roberts B, et al. Role of transforming growth factor-β signaling in cancer[J]. J Natl Cancer Inst,2000,92(17) :1388-1402.
-
3Howell M, hoh F, Pierreux CE, et al. Xenopus Smad 4 beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction ofearly mesodermal genes [J]. Dev Biol, 1992, 214 (2) : 354-369.
-
4Massague J, Chem YG. Controlling TGF-beta Signaling[J].Genes Dev,2000,14(3) :627-644.
-
5Yagi K,Goto D, Hamamoto T, et al. Alternatively spliced variant of Smad 2 lacking exon 3 comparison with wild-type Smad 2 and Smad 3[J]]. J Biol Chem, 1999, 274(3): 703-709.
-
6Onichtchouk D, Chen YG, Dosch R, et al. Silencing of TGF-beta signaling by the pseudoreceptor BAMBI[J]. Nature, 1999,401(5) :480-485.
-
7Bitzer M,von Gersdorff G,Liang D, et al. A mechanism ofsuppression of TGF-beta/SMAD signaling by NF-kappa B/RelA[J]. Genes Dev, 2000,14 ( 1 ) : 187-197.
-
8Muler KM. Role of Ras and Mapks in TGF beta signaling[J]. Cytokine Growth Factor Rev, 2000,11 ( 1 ): 23-25.
-
9Calonge MJ, Massague J. Smads4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells[-J-]. J BiolChem,1997,274(Ⅲ,15) :33637-33643.
-
10Yahata T, de Caestecker MP, Lechleider RJ, et al. The MSG1 non-DNA-binding transactivator binds to the p300,/CBP coactivators, enhancing their functional link to the Smad transcription factors[J]. J Biol Chem, 2000,274 (36) :8825-8834.
-
1张友才,刘长生,朱尤庆.转化生长因子-β信号转导与肿瘤[J].国外医学（临床生物化学与检验学分册）,2002,23(5):263-264.
-
2曹海霞,诸琦.Smad4在胰腺癌发病机制中的研究进展[J].胰腺病学,2007,7(5):351-352. 被引量：1
-
3李金鹏,于红刚.联合抑制Notch和PI3K/Akt通路对胃癌细胞增殖的影响[J].胃肠病学和肝病学杂志,2013,22(8):783-785. 被引量：1
-
4周清.表皮生长因子受体突变丰度预测吉非替尼治疗晚期非小细胞肺癌疗效[J].循证医学,2011,11(4):237-237.
-
5陈佳艳,樊旼.智能扩增检测法检测非小细胞肺癌患者血浆及肿瘤组织中表皮生长因子受体突变的研究[J].中华结核和呼吸杂志,2012,35(8):619-620. 被引量：1
-
6朱军,张洁,陈墨,周彩存.非小细胞肺癌表皮生长因子受体突变阴性患者化疗疗效分析[J].中华肿瘤杂志,2013,35(5):386-388. 被引量：7
-
7孙宏斌,夏术阶.雄激素受体突变与前列腺癌内分泌治疗失效[J].国外医学（泌尿系统分册）,2004,24(2):181-184.
-
8马建国,李文平,蒋玉清.雄激素受体突变在前列腺癌进展中的作用[J].中华男科学杂志,2011,17(7):649-654. 被引量：4
-
9胡兴胜.内皮生长因子受体突变非小细胞肺癌精准个体化治疗[J].武警医学,2015,26(8):757-760. 被引量：1
-
10刘涓,孙威.IL-6和IGF-1在非小细胞肺癌组织的表达与临床意义[J].中国组织化学与细胞化学杂志,2015,23(5):399-403. 被引量：15
